Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2005 May 28;330(7502):1269; author reply 1270-1.
doi: 10.1136/bmj.330.7502.1269.

Angiotensin receptor blockers and myocardial infarction: analysis of evidence is incomplete and inaccurate

John McMurray
Comment

Angiotensin receptor blockers and myocardial infarction: analysis of evidence is incomplete and inaccurate

John McMurray. BMJ. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Verma S, Strauss M. Angiotensin receptor blockers and myocardial infarction. BMJ 2004;329: 1248-9. (27 November.) - PMC - PubMed
    1. Dickstein K, Kjekshus J, OPTIMAAL Steering Committee of the OPTIMAAL Study Group. Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal trial in myocardial infarction with angiotensin II antagonist losartan. Lancet 2002;360: 752-60. - PubMed
    1. Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Kober L, Maggioni AP, et al. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 2003;349: 1893-906. - PubMed
    1. Pfeffer MA, Swedberg K, Granger CB, Held P, McMurray JJ, Michelson EL, et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-OVERALL programme. Lancet 2003;362: 759-66. - PubMed
    1. Berl T, Hunsicker LG, Lewis JB, Pfeffer MA, Porush JG, Rouleau JL, et al. Cardiovascular outcomes in the irbesartan diabetic nephropathy trial of patients with type 2 diabetes and overt nephropathy. Ann Intern Med 2003;138: 542-9. - PubMed

MeSH terms

Substances